ACTICOAT* 7 Silver-Coated Antimicrobial Barrier Dressings are used to manage wounds by providing broad-spectrum bactericidal activity against 120+ pathogens in 30 minutes.
• Proprietary silver technology
• Broad-spectrum antimicrobial activity against over 120 organisms including 200 strains of MRSA and 5 organisms that carry the NDM-1 enzyme (in vitro)
• Seven day wear time
• Provides bactericidal activity within 30 minutes
• May help reduce the risk of infection
• Can be used on extensive body surface area wounds and over debrided wounds
• Can be cut to size
ACTICOAT* Dressings are indicated as an antimicrobial barrier for the management of partial- and full-thickness wounds such as pressure ulcers, leg ulcers, diabetic foot ulcers, first- and second-degree burns, and donor sites.
Do not use on patients with a known sensitivity to silver. During MRI (Magnetic Resonance Imaging) examination, remove from area being imaged. Prior to administering radiation therapy, remove ACTICOAT*. A new dressing can be applied following treatment.
For external use only. ACTICOAT* is not compatible with oil-based products, such as petrolatum. Avoid contact with electrodes or conductive gels during electronic measurements e.g. EEG and ECG. Do not use saline.
May cause transient discoloring of surrounding skin.
Avoid exposure to temperatures above 50°C. Protect from light.
|Absorptive dressing format|
|Alginate dressing format|
|Antimicrobial effects up to 3 days|
|Antimicrobial effects up to 48 hours|
|Antimicrobial effects up to 7 days||●|
|Collagen dressing format|
|Composite dressing format|
|Contact layer dressing format||●|
|Foam dressing format|
|Gauze or non-woven dressing format|
|Hydrogel (amorphous) dressing format|
|Hydrogel (impregnated) dressing format|
|Hydrogel (sheet) dressing format|
|Impregnated dressing format|
|Moisture vapor permeable|
|Secondary dressing required||●|
|Sustained release formula||●|
|Transparent film dressing format|
|Wound filler dressing format|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available||●|
Grafts and Donor Sites
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
Follow standard protocol to cleanse wound; do not use oil-based cleansing agents.
For heavily exudative wounds:
Remove the ACTICOAT* 7 dressing from the package and cut to size. Apply the dry ACTICOAT* 7 dressing to the wound, either side down, as the exudate will be sufficient to activate the dressing. Cover the ACTICOAT* 7 dressing with an absorbent secondary dressing.
For all other wounds:
Remove the dressing from package and cut to shape of wound. Moisten the dressing with sterile water (do not use saline). Allow the dressing to drain on an absorbent surface in a sterile field for at least 2 minutes. Apply the dressing to the wound surface, either side down. Cover the dressing with a moist absorbent secondary dressing.
If the dressing dries and adheres to the wound, moisten or soak the dressing prior to removal. Avoid forceful removal of the dressing and disruption of the healing wound.
ACTICOAT* 7 Dressings can be left on wounds for up to seven days.
ACTICOAT* Dressings can be used under compression therapy.
For over 150 years, Smith & Nephew has taken a pioneering approach to product design and services, helping to reduce the human and economic costs of wounds.
Advanced Wound Bioactives
(Includes Collagenase SANTYL* Ointment, OASIS® Ultra Tri-Layer Matrix, OASIS® Wound Matrix, PROSHIELD* Foam & Spray Incontinent & Total Body Cleanser, PROSHIELD* Plus Skin Protectant, REGRANEX* (becaplermin) Gel 0.01%)
Toll-free: (800) 441-8227
Fax: (817) 900-4100
Advanced Wound Care or Devices
(Includes all other products listed below)
Toll-free: (800) 876-1261
Fax: (727) 392-6914